Oxford Textbook of Neuro-Oncology (Oxford Textbooks in Clinical Neurology) – November 2017 Release

 Neurology/Neurosurgery, Oncology  Comments Off on Oxford Textbook of Neuro-Oncology (Oxford Textbooks in Clinical Neurology) – November 2017 Release
Jun 192018

Part of the Oxford Textbooks in Clinical Neurology series, the Oxford Textbook of Neuro-Oncology covers the pathophysiology, diagnosis, classification, and management of tumours of the nervous system. The book provides a comprehensive overview of tumour subtypes, in accordance with WHO classifications, along with management plans for adult and paediatric populations. The international team of co-editors ensures that expert commentaries on existing and wide-reaching diagnostic and treatment guidelines (including NCCN and ESMO) are accessible by a global audience.



Share Button

Manual of Clinical Oncology – 8th Edition (April 2017 Release)

 Oncology  Comments Off on Manual of Clinical Oncology – 8th Edition (April 2017 Release)
Jun 182018

Concise, portable, and packed with essential information, Manual of Clinical Oncology is an indispensable resource for understanding basic science, clinical findings, and available technology as they relate to the diagnosis and management patients with cancer.  The practical format provides high-yield content useful for participating in rounds ad making diagnostic and therapeutic decisions at the bedside.  Edited by Dr. Bartosz Chmielowski  and Dr. Mary Territo, both from UCLA School of Medicine, this eighth edition carries on the tradition of excellence set forth by longtime editor Dr. Dennis Casciato.

Key Features:

  • Incorporates recent major achievements in immunotherapies, biologics, and targeted therapies.
  • Features new chapters on the biology of cancer, immunotherapy, and cancer survivorship.
  • Contains numerous diagnostic and treatment algorithms, as well as content on complications, for assistance with clinical decision making.
  • Includes helpful appendices such as a glossary of cytogenetic nomenclature and combination chemotherapy regimens.

Your book purchase includes a complimentary download of the enhanced eBook for iOS, Android, PC & Mac. Take advantage of these practical features that will improve your eBook experience:

  • The ability to download the eBook on multiple devices at one time — providing a seamless reading experience online or offline
  • Powerful search tools and smart navigation cross-links that allow you to search within this book, or across your entire library of VitalSource eBooks
  • Multiple viewing options that enable you to scale images and text to any size without losing page clarity as well as responsive design
  • The ability to highlight text and add notes with one click

Editorial Reviews


Share Button

Gastrointestinal Cancers : Prevention, Detection and Treatment, Volume 2

 Gastroenterology/Hepatology, Oncology  Comments Off on Gastrointestinal Cancers : Prevention, Detection and Treatment, Volume 2
Jun 142018

Gastrointestinal (GI) cancer is well known cancer of digestive system that includes cancer of esophagus, gallbladder, liver, pancreas, stomach, small intestine, large intestine, rectum and anus. The incidence of GI cancer is higher in developed countries than developing counties. In developed countries such as United States, GI cancer accounts to 20 percent of all newly diagnosed cancer cases. In the developing countries inside Asia the burden of GI cancer is increasing because of aging, growth of the population and the risk factors including smoking, obesity, changing lifestyle and high prevalence of H pylori, HBV and HCV. In most developing countries, cancer control programs or early detection and treatment services are limited despite this increase.

Pancreatic cancer is the fourth commonest cause of cancer-related mortality across the world. This cancer is the fifth-most-common cause of cancer deaths in the United States and the seventh most common cancer in Europe. The majority of cases are diagnosed in the advanced stages, making curative therapy impossible and leading to poor prognosis and incidence equaling mortality. It has been estimated that rates of pancreatic cancer have been increasing slightly over the past decade. Pancreatic cancer is a very lethal and aggressive cancer and diagnosis is delayed, as the symptoms appear when the cancer is in advanced stage.

Liver cancer (also called hepatic cancer) is a cancer that originates in the hepatic cells, also known as primary liver cancer. Some cancers arise in other part of body and metastasize in the liver called secondary or metastatic liver cancer. The most common form of liver cancer is hepatocellular carcinoma, which begins in the liver cell (hepatocyte). Primary liver cancer accounts for about 2% of cancers in the USA, but up to half of all cancers in some developing countries due to the prevalence of infections specifically by hepatitis virus.

On the basis of various incidences of different gastrointestinal cancer motivates us to compile a book related to gastrointestinal cancers and focus on the almost all type of prevention, detection and treatment methods from the world experts. This book is the culmination of the efforts of several researchers, junior and senior clinicians as well scientists as per their field of expertise across the world. In this book authors focused on different gastrointestinal cancers and describe the various methods for prevention, detection and treatment. The book has enormous scope and will benefit multiple audience including researchers, clinicians, patients, academicians, industrialists, and students.



Share Button

Surgery for Pancreatic and Periampullary Cancer: Principles and Practice

 Oncology, Surgery  Comments Off on Surgery for Pancreatic and Periampullary Cancer: Principles and Practice
Jun 132018

This book covers the full range of advanced surgical techniques for pancreatic and periampullary cancers with a focus on major and minor operative techniques and reconstruction methods. Globally respected surgeons share their expertise and personal views in a “how I do it” manner, supplemented by high-quality illustrations. Starting with initial chapters on surgical anatomy, an overview of these cancers, their classification and imaging, subsequent chapters address surgical techniques for resection and reconstruction in detail. The book also included dedicated chapters on complications, preoperative and postoperative management protocols, pathologic reporting, and the impact of nutrition on the outcome. Divided into 28 chapters, it provides an up-to-date, practical guide to the diagnosis and management of pancreatic cancers for both young and experienced HPB and GI surgeons alike.
Share Button

Gynecologic Oncology Handbook, Second Edition

 Ob/Gynae, Oncology  Comments Off on Gynecologic Oncology Handbook, Second Edition
Jun 132018

Now in its second edition, Gynecologic Oncology Handbook: An Evidence-Based Clinical Guide has been thoroughly updated to include the latest advances in surgical techniques, chemotherapy protocols, AJCC 8th Edition staging criteria, and much more. This current edition contains illustrations that reinforce key concepts, algorithms for diagnostic techniques, and tables to guide you in optimal disease management.

The handbook covers the spectrum of gynecologic oncology from seminal studies to guide the oncologist, to the essential workup for the Obstetrician/Gynecologist and related clinician. This handbook can be carried by the practitioner on the ward or in the clinic. It includes necessary details on gynecologic cancer screening and treatment regimens for preinvasive disease, to staging and management of all the gynecologic cancers such as cervical cancer, ovarian cancer, uterine cancer, vulvar cancer, vaginal cancer, and gestational trophoblastic disease. It highlights evidence-based best practices for managing these cancers, hereditary cancer syndromes, for surgical care, and for all adjuvant therapies including chemotherapy, radiation therapy, targeted therapies, and immunotherapies. Detailed sections on survivorship care, palliative care, as well as managing reproductive function and other comorbid medical conditions make this a ‘one-stop shop’ for navigating all clinical aspects and effects of gynecologic cancer.

Featuring new and important clinical study references, medical comorbidity algorithms, directed gynecologic cancer workups and treatments, numerous tables and easy-to-reference illustrations, the Gynecologic Oncology Handbook, 2nd Edition is the ultimate quick reference for the clinical management of all gynecologic malignancies and related conditions.

Key Features:

Covers all fundamentals of gynecologic oncology including workup, staging, surgical management, chemotherapy and radiation therapy treatment, comorbidity diagnosis and management, and background study data
Provides Gynecologic Oncology Referral Parameters, Performance Status Scales, Adverse Event Grading, RECIST evaluation criteria, chemotherapy protocols, statistics, and other useful formulas.
Includes clinical study references, medical comorbidity algorithms, directed workups, and treatment guidelines
Includes digital access to the eBook



Share Button

Fast Facts: Prostate Cancer, 9th edition

 Oncology  Comments Off on Fast Facts: Prostate Cancer, 9th edition
Jun 132018

Prostate cancer is unusual among solid tumors in that the majority of affected men die with, rather than of, the disease. This presents many challenges to healthcare professionals and patients in terms of deciding if, when and how to intervene in order to control tumor growth and spread, thereby extending survival but without compromising quality of life.
This is the ninth edition of Fast Facts: Prostate Cancer since 1996, testament to the rapid changes in the field and the steadily improving outlook for patients.

This new edition provides many key updates:

– the Gleason grade grouping, which has valuable prognostic value

– nomograms to evaluate risk

– our rapidly expanding understanding of the genetics and underlying pathogenesis of prostate cancer and the development of genomic tests to help identify those at greatest risk of developing clinically significant disease

– the continuing debate about the role of PSA in the screening, detection and monitoring of prostate cancer

– advances in imaging techniques, particularly multiparametric MRI, which is improving the accuracy of biopsy and reducing the numbers of negative biopsies

– the roles of drugs, surgery and radiotherapy in the treatment of prostate cancer at different stages, and our ever-improving understanding of when and how best to intervene, aided by improving understanding of the risk factors for disease progression.

Primarily intended for primary care providers, specialist nurses, junior doctors and allied healthcare professionals, this highly readable resource provides a comprehensive overview of prostate cancer, enabling fully informed discussions with patients about this complex disease

If you are a clinician and you’re going to read only one easy-to-read book about prostate cancer, make it this one. Then lend it to those patients who wish to know more. –Inderbir S. Gill, Keck School of Medicine



Share Button

Prostate Cancer: Methods and Protocols

 Oncology  Comments Off on Prostate Cancer: Methods and Protocols
Jun 132018

This volume presents methods and protocols on modern analysis of steroid receptor and prostate cancer function. Chapters detail androgen, androgen receptor action, anti-androgen enzalutamide, in vitro and in vivo models, imaging, gene fusions, and help facilitate studies with novel drugs including anti-androgens and chemotherapeutics. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and cutting-edge, Prostate Cancer: Methods and Protocols aims to provide easily reproducible techniques.



Share Button

Mass Spectrometry in Cancer Research

 Oncology  Comments Off on Mass Spectrometry in Cancer Research
Jun 132018

Cancer research is becoming multidisciplinary. The complex structural and therapeutic problems require synergistic approaches employing an assortment of biochemical manipulations, chromatographic or electrophoretic separations, sequencing strategies, and … more and more mass spectrometry.
Mass Spectrometry in Cancer Research provides a broad examination of current strategies and techniques and their application to the study of:
(i) occupational and environmental carcinogens;
(ii) antineoplastic and chemopreventive agents;
(iii) pertinent proteins, lipids, nucleic acids and glycoconjugates. Also included are a chapter on instrumentation and methodologies for biologists and physicians and a brief review of the relevant concepts of cancer biology and medicine for mass spectrometrists.
This book is intended for: mass spectrometrists in research or those providing core services; researchers in biological, medical, pharmaceutical or environmental sciences; physicians in academic medicine; and academic/industrial research managers.



Share Button

Quality Cancer Care: Survivorship Before, During and After Treatment

 Oncology  Comments Off on Quality Cancer Care: Survivorship Before, During and After Treatment
Jun 132018

Maintaining quality and improving cancer care does not occur in a vacuum. It requires a coordinated effort among many team members to whom this book is directed. Cancer care in the United States is in crisis as per a recent National Institute of Health publication. Much of this has to do with the complexity of the cancer care, its delivery systems, the aging population and the diminishing workforce. We need to be smarter and more efficient to de-escalate this crisis and improve the survival and survivorship of our cancer patients. Improved survivorship of families and caregivers will be included as well.
The book will follow the continuum of cancer care model as its outline vide infra. It will provide many concrete instances of successful practices and programs which improve survivorship. Initially it will discuss the current crisis on a global and then national platform. There will be a discussion about disability adjusted life years lost, lost productivity, loss of life and its impact upon the nation and communities. The financial impact of cancer on society and government will be included in this. Population health management as regards cancer will then look at communities served, community health needs assessments and social determinants of health. How prevention and screening programs can be formulated from the above will be illustrated.
Compliance with treatments as promulgated by the Commission on Cancer’s Cancer Program Practice Performance Reports (CP3R) will be reviewed. The relationship between compliance and improved survival will be highlighted. Navigation and distress management to assure patients complete planned treatments will be included in this section.
Quality of survivorship will review the four domains of life- spiritual, social, psychological and physical. How these can be maximized through system improvement and program development will be illustrated. Financial issues and legal protections will also be included in this section. Survivorship care planning i.e. surveillance for recurrent cancer, prevention of related and new cancers will be an integral part of this section.
Palliative, end of life care and bereavement care will complete the continuum cycle. Identifying hospitalized patients in need of palliative needs will be refreshed. How to establish an in-patient palliative care team and creating a seamless transition from in-patient to out-patient palliative care will be presented.
Intended AudienceAdministrative and clinical staff involved in the delivery of cancer care including: hospital executives, physicians, nurses, radiation therapists, psychology counselors, social workers, physical therapists, occupation therapists, nutritionists, government, healthcare insurance representatives, etc.




Share Button

Gastric Cardiac Cancer

 Gastroenterology/Hepatology, Oncology  Comments Off on Gastric Cardiac Cancer
Jun 132018

This book is designed to present readers with comprehensive, high-quality research results on almost all aspects of this carcinoma in clinical management, from correct determination of the esophagogastric junction, issues on cardiac mucosa, epidemiology, and natural history, to clinical, endoscopic, and histopathologic features and diagnostic pitfalls of this carcinoma at both early and advanced stages. Once diagnosed and correctly staged, clinical management of this carcinoma at the early stage is addressed primarily with endoscopic therapy employing the latest endoscopic technology such as endoscopic submucosal dissection, in which detailed technical topics of the endoscopic therapy are written by experts in the field with sections from pre-resection staging and patient preparation to post-resection complications and management.
Subsequently, clinical management of gastric cardiac carcinoma at advanced stages is discussed at length with a personalized, multidiscipline approach with strategies from surgical resections with various methods, to pre-, peri- and post-resection chemoradiation therapies as well as the most advanced immunotherapy. A state-of-art approach with the results of meta-analyses and large-scale randomized double-blinded clinical trials are employed throughout these chapters. For patients at the terminal ill stage, the appropriate palliative care plan is presented by experienced clinicians armed with the latest clinical practice guidelines to better manage and help those patients in the last period of their lives.




Share Button